Martin Shkreli, the investor and convicted securities fraudster widely referred to as “Pharma Bro,” has claimed that he and Barron Trump, the former president’s youngest son, are behind the ...

Why do they call Martin shkreli Pharma Bro? Mr. Shrkeli played a major role in driving up the price of Daraprim, a toxoplasmosis drug, which the Swiss company owns the rights to, earning him the ...

"I told Martin I loved him," Christie Smythe recalled of one prison visit with Martin Shkreli. "And he told me he loved me, too" Christie Smythe, a former crime reporter for Bloomberg News ...

Major” tariffs on pharmaceutical imports are coming soon, President Donald Trump says, pledging that they’d help bring drug ...

A New York judge is desperately searching for people who don't hate Martin Shkreli's guts. The infamous ex-pharmaceutical company exec is set to stand trial for security fraud charges unrelated to ...

In a Spaces interview on X, 'Pharma Bro' Martin Shkreli alleged that he created the DJT cryptocurrency with Barron Trump. Convicted Pharma Bro Martin Shkreli makes surprise appearance at SBF trial ...

Martin Shkreli, the controversial former hedge fund manager known as “Pharma Bro,” questioned but ultimately defended Palantir Technologies Inc.‘s PLTR growth projections on Wednesday ...

January 16, 2025 • You remember a guy named Martin Shkreli? If his name rings a bell, it's probably because back in 2015, he jacked up the price of an old drug — from around $13 a pill to $750.

It always seemed a little odd that Martin Shkreli, awkward yet diabolical pharma bro, saw fit to criticize legendary rappers the Wu-Tang Clan. His copious sulking and slams against the group ...

A New York federal judge ordered Martin Shkreli to surrender any copies of the one-of-a-kind Wu-Tang Clan album "Once Upon a Time in Shaolin" in response to a complaint from the record's new owner.

Martin Shkreli was sentenced to seven years in prison last year for looting a drug company he founded, Retrophin, of $11 million to pay back investors in two failed hedge funds he ran. Martin ...